(OTC: KKUR) Cancer Detection Method Gaining Acceptance in the Medical Community
2010年4月12日 - 8:30PM
Marketwired
ChromoCure, Inc. (PINKSHEETS: KKUR) recently announced the newest
specifications on its CS300 Series Chromosomal Scanner.
ChromoCure's proprietary method of cancer detection, the
"aneuploidy theory," was the focus of the 1st Conference of
Aneuploidy and Cancer: Clinical and Experimental Aspects in
Oakland, California.
(http://mcb.berkeley.edu/labs/duesberg/pdfs/duesberg_cell%20cycle_2004.pdf)
The "aneuploidy theory" reportedly "held its weight" and was proven
relevant by several independent labs during the conference. This
further liberates aneuploidy theory from the competing gene
mutation theory.
The Company's proprietary Chromosomal Scanner systems have
proven accurate and efficient in measuring the unique
characteristics found in 100% of all cancers at all stages.
For more information, please visit www.chromocure.com
Other active stocks are Millipore Corporation (NYSE: MIL) Life
Technologies Corp (NASDAQ: LIFE) and eTotalSource Inc (PINKSHEETS:
ETLS)
Information, opinions and analysis contained herein are based on
sources believed to be reliable, but no representation, expressed
or implied, is made as to its accuracy, completeness or
correctness. The opinions contained herein reflect our current
judgment and are subject to change without notice. We accept no
liability for any losses arising from an investor's reliance on or
use of this report. This report is for information purposes only,
and is neither a solicitation to buy nor an offer to sell
securities. A third party has hired and paid IO News Wire twelve
hundred and ninety five dollars for the publication and circulation
of this news release. Certain information included herein is
forward-looking within the meaning of the Private Securities
Litigation Reform Act of 1995, including, but not limited to,
statements concerning manufacturing, marketing, growth, and
expansion. Such forward-looking information involves important
risks and uncertainties that could affect actual results and cause
them to differ materially from expectations expressed herein. We
have no ownership of equity, no representation; do no trading of
any kind and send no faxes or emails.
Contact: Eric Jensen www.ionewswire.com 516.942.4910
Chromocure (CE) (USOTC:KKUR)
過去 株価チャート
から 5 2024 まで 6 2024
Chromocure (CE) (USOTC:KKUR)
過去 株価チャート
から 6 2023 まで 6 2024
Real-Time news about Chromocure Inc (CE) (その他OTC): 0 recent articles
その他のIO News Wireニュース記事